Year: 2026

Ramp launches in UK, trumpets AI token spend platform

Ramp launches in UK, trumpets AI token spend platform US expense management startup Ramp has launched in the UK, landed ElevenLabs as a client, and is trumpeting its AI token spend platform as it looks to woo more UK startup clients. Ramp’s launch in the UK, its first outside North

UK ClimateTech startup Isometric brings Series A to €43 million as it expands beyond carbon removal

UK ClimateTech startup Isometric brings Series A to €43 million as it expands beyond carbon removal Isometric, a London-based certifier for the industrial economy, today announced that their Series A has reached €43 million ($50 million) to accelerate its expansion with the help of new investors. EU-Startups understands today’s investment

Crane Venture Partners raises €419 million as it expands across Europe, APAC and the US

Crane Venture Partners raises €419 million as it expands across Europe, APAC and the US London’s Crane Venture Partners today announced that they have raised €419 million ($484 million) across four investment vehicles, as well as their plans to create an inception-to-Seed venture platform in partnership with MassMutual Ventures (MMV).

London-based Jack & Jill raises €34.68 million Series A to scale its AI agents for jobseekers and employers

London-based Jack & Jill raises €34.68 million Series A to scale its AI agents for jobseekers and employers Jack & Jill, the London-based startup that puts an AI agent on each side of the hiring table, has raised €34.68 million ($40 million) in a Series A round. The round was

Exein reaches Unicorn status as it faces 5,000 attacks weekly and raises €234 million for Physical AI cybersecurity

Exein reaches Unicorn status as it faces 5,000 attacks weekly and raises €234 million for Physical AI cybersecurity Exein, a Physical AI cybersecurity company out of Rome, today announced €234 million ($270 million) in new funding at a €1.4 billion ($1.7 billion) valuation, reportedly making it the most valuable cybersecurity

Magnitude Biosciences secures €1.5 million investment to scale in-vivo drug discovery platform

Magnitude Biosciences secures €1.5 million investment to scale in-vivo drug discovery platform Magnitude Biosciences, a specialist contract research organisation (CRO) and Durham University spinout, has secured €1.5 million (£1.3 million) in funding to accelerate the commercialisation of VivoScan, its proprietary in vivo high-throughput screening (HTS) platform. Northstar Ventures led the